Compare
Iridex Corp vs electroCore, Inc. vs Ceribell, Inc. vs Vaso Corp
| Latest fiscal year | Iridex Corp IRIX | electroCore, Inc. ECOR | Ceribell, Inc. CBLL | Vaso Corp VASO |
|---|---|---|---|---|
| Year ended | 2026-01-03 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $52.67M | $32.03M | $89.06M | $89.10M |
| Revenue growth (YoY) | +8.2% | +27.2% | +36.1% | +2.7% |
| Gross margin | 36.5% | 86.8% | 87.9% | 61.4% |
| Operating margin | -4.9% | -41.1% | -65.6% | -3.2% |
| Net margin | -8.4% | -43.6% | -60.0% | 1.8% |
| Net income | -$4.44M | -$13.97M | -$53.41M | $1.57M |
| EPS (Diluted) | -$0.26 | -$1.65 | -$1.46 | $0.01 |
| Operating cash flow | -$2.12M | -$8.19M | -$40.81M | $9.27M |
| Free cash flow | -$2.26M | -$8.25M | -$41.58M | n/a |
| Cash & equivalents | $6.03M | $7.04M | $40.48M | $35.05M |
| Total assets | $29.15M | $18.67M | $195.80M | $88.35M |
| Total liabilities | $24.23M | $20.38M | $40.47M | n/a |
| Shareholders' equity | $4.92M | -$1.71M | $155.34M | $29.43M |
| Return on year-end equity | -90.1% | n/a | -34.4% | 5.3% |
| Shares outstanding | 17.31M | 8.00M | 37.49M | 175.95M |
Revenue, most recent five fiscal years
| Fiscal year | Iridex Corp | electroCore, Inc. | Ceribell, Inc. | Vaso Corp |
|---|---|---|---|---|
| Latest | $52.67M Ended 2026-01-03 | $32.03M Ended 2025-12-31 | $89.06M Ended 2025-12-31 | $89.10M Ended 2025-12-31 |
| 1 year earlier | $48.67M Ended 2024-12-28 | $25.18M Ended 2024-12-31 | $65.44M Ended 2024-12-31 | $86.77M Ended 2024-12-31 |
| 2 years earlier | $51.87M Ended 2023-12-30 | $16.03M Ended 2023-12-31 | $45.23M Ended 2023-12-31 | $81.02M Ended 2023-12-31 |
| 3 years earlier | $56.97M Ended 2022-12-31 | $8.59M Ended 2022-12-31 | n/a | $79.29M Ended 2022-12-31 |
| 4 years earlier | $53.90M Ended 2022-01-01 | $5.45M Ended 2021-12-31 | n/a | $75.58M Ended 2021-12-31 |